A Multinational Investigation of the Impact of Subcutaneous Sumatriptan

The associations of migraines and other headaches with work performance: Results from the National Comorbidity Survey Replication (NCS-R)

“…Such experiments have not been carried out, although a significant effect of migraine medication with triptans versus placebo on self-reported work productivity was documented in a randomized clinical trial (58) and significant before-after reductions in sickness absence were documented in several open-label studies of migraine treatment in workplace samples (59-62). These results suggest that large-scale workplace effectiveness trials are warranted for workers with frequent or severe migraines.…”

The cost of the migraine patient in Italy

“…It is well-known that migraine sufferers do miss work or work at reduced efficiency. Loss of productivity is not easy to calculate since the absence of an employee may be offset by colleagues or flexible working practices such as "flexitime" [10], with partial or complete recovery of the lost productivity. Nonetheless, since migraine is a chronic disease, the disability it causes is the highest cost for society as a whole [11,12], making a calculation of long-term effects a worthwhile study [13].…”

Handbook of Complex Occupational Disability Claims

“…This implies that reducing migraine symptoms will improve functioning, and indeed data have been supportive (e.g., Cortelli, Dahlöf, Bouchard, Heywood, Jansen, Pham, Hirsch, Adams, & Miller, 1997;Wells & Steiner, 2000). Conversely, factors that predict a long-term increase in migraine frequency would augur increased disability as well.…”